EPISODE · May 20, 2026 · 5 MIN
Critical Medicines Act Agreement and JCA Operational Momentum
Episode 13 — 20 May 2026 Political agreement on the EU Critical Medicines Act strengthens supply chain preparedness while IQWiG advances multiple JCA oncology assessments. NICE approves zanidatamab for rare biliary tract cancer as real-world evidence research emerges from ISPOR 2026. Hosted by Marcus and Sara. Outcomes Analytica Podcast — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
What this episode covers
Episode 13 — 20 May 2026 Political agreement on the EU Critical Medicines Act strengthens supply chain preparedness while IQWiG advances multiple JCA oncology assessments. NICE approves zanidatamab for rare biliary tract cancer as real-world evidence research emerges from ISPOR 2026. Hosted by Marcus and Sara. Outcomes Analytica Podcast — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
NOW PLAYING
Critical Medicines Act Agreement and JCA Operational Momentum
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m